BlackRock Inc (NYSE:BLK) reports second-quarter results before the bell on July 15, and UBS is telling clients this is a good time to be holding the stock. The bank's case: an attractive valuation paired with a rare combination of growth and defensiveness.
BlackRock (BLK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BlackRock built a massive business around exchange-traded funds. The company's current focus is to build out its private markets business, which could be a much more profitable opportunity.
BlackRock (BLK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The latest trading day saw BlackRock (BLK) settling at $980.38, representing a +1.96% change from its previous close.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does BlackRock (BLK) have what it takes?
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Investors interested in Financial - Investment Management stocks are likely familiar with Affiliated Managers Group (AMG) and BlackRock (BLK). But which of these two stocks is more attractive to value investors?
BlackRock (BLK) closed at $971.92 in the latest trading session, marking a -1.09% move from the prior day.
Over the quarter, the BlackRock Health Sciences Term Trust increased its exposure to pharmaceuticals and biotechnology firms. Within the pharmaceuticals subsector, the Trust initiated positions in GSK and Vertex Pharmaceuticals, due to positive fundamentals and progress in a rare disease program, respectively. Elsewhere, the Trust reduced its exposure to medical devices & supplies companies, which included locking in profits.
BlackRock (NYSE: BLK) is paying its latest quarterly dividend today, June 23, rewarding shareholders with a cash distribution of $5.73 per share.
BLK is cutting nearly 200 jobs, under 1% of staff, as it balances acquisition-driven growth, private market expansion and efficiency goals.